Structural Models of Amyloid-Like Fibrils

Advances in Protein Chemistry

Volumn 73, Issue , 2006, Pages 235-282

  Nelson, Rebecca ^a   Eisenberg, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CONGO RED; CYSTATIN C; INSULIN; MYOGLOBIN; POLYGLUTAMINE; PREALBUMIN; PRION PROTEIN; PRION PROTEIN HET S; PRION PROTEIN URE2P; SUPEROXIDE DISMUTASE;

PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW;

AMYLOID; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 33845652277     PISSN: 00653233     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3233(06)73008-X     Document Type: Review

References (192)

1. Abrahamson M. Molecular basis for amyloidosis related to hereditary brain hemorrhage. Scand. J. Clin. Lab. Invest. Suppl. 226 (1996) 47-56
2. Adams M.J., Blundell T.L., Dodson E.J., Dodson G.G., Vijayan M., Baker E.N., Harding M.M., Hodgkin D.C., Rimmer B., and Sheat S. Structure of rhombohedral 2 zinc insulin crystals. Nature 224 (1969) 491-495
3. Anfinsen C.B. Principles that govern the folding of protein chains. Science 181 (1973) 223-230
4. Antzutkin O.N., Balbach J.J., Leapman R.D., Rizzo N.W., Reed J., and Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. USA 97 (2000) 13045-13050
5. Antzutkin O.N., Leapman R.D., Balbach J.J., and Tycko R. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41 (2002) 15436-15450
6. Astbury W.T., Dickinson S., and Bailey K. The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem. J. 29 (1935) 2351-2360
7. Balbach J.J., Ishii Y., Antzutkin O.N., Leapman R.D., Rizzo N.W., Dyda F., Reed J., and Tycko R. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39 (2000) 13748-13759
8. Balbach J.J., Petkova A.T., Oyler N.A., Antzutkin O.N., Gordon D.J., Meredith S.C., and Tycko R. Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: Evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 83 (2002) 1205-1216
9. Balbirnie M., Grothe R., and Eisenberg D.S. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc. Natl. Acad. Sci. USA 98 (2001) 2375-2380
10. Balguerie A., Dos Reis S., Ritter C., Chaignepain S., Coulary-Salin B., Forge V., Bathany K., Lascu I., Schmitter J.M., Riek R., and Saupe S.J. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22 (2003) 2071-2081
11. Baxa U., Taylor K.L., Wall J.S., Simon M.N., Cheng N., Wickner R.B., and Steven A.C. Architecture of Ure2p prion filaments: The N-terminal domains form a central core fiber. J. Biol. Chem. 278 (2003) 43717-43727
12. Baxa U., Cheng N., Winkler D.C., Chiu T.K., Davies D.R., Sharma D., Inouye H., Kirschner D.A., Wickner R.B., and Steven A.C. Filaments of the Ure2p prion protein have a cross-beta core structure. J. Struct. Biol. 150 (2005) 170-179
13. Baxa U., Cassese T., Kajava A.V., and Steven A.C. Structure, function, and amyloidogenesis of fungal prions: Filament polymorphism and prion variants. Adv. Protein Chem. 73 (2006) 125-180
14. Bennett M.J., Schlunegger M.P., and Eisenberg D. 3D domain swapping: A mechanism for oligomer assembly. Protein Sci. 4 (1995) 2455-2468
15. Benson M.D., and Uemichi T. Transthyretin amyloidosis. Amyloid Int. J. Exp. Clin. Investig. 3 (1996) 44-56
16. Benyamini H., Gunasekaran K., Wolfson H., and Nussinov R. Beta2-microglobulin amyloidosis: Insights from conservation analysis and fibril modelling by protein docking techniques. J. Mol. Biol. 330 (2003) 159-174
17. Benzinger T.L., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., and Meredith S.C. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA 95 (1998) 13407-13412
18. Benzinger T.L., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., and Meredith S.C. Two-dimensional structure of beta-amyloid (10-35) fibrils. Biochemistry 39 (2000) 3491-3499
19. Bevivino A.E., and Loll P.J. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils. Proc. Natl. Acad. Sci. USA 98 (2001) 11955-11960
20. Blake C., and Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4 (1996) 989-998
21. Blake C.C., Geisow M.J., Oatley S.J., Rerat B., and Rerat C. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121 (1978) 339-356
22. Bode W., Engh R., Musil D., Thiele U., Huber R., Karshikov A., Brzin J., Kos J., and Turk V. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7 (1988) 2593-2599
23. Bond J.P., Deverin S.P., Inouye H., el-Agnaf O.M., Teeter M.M., and Kirschner D.A. Assemblies of Alzheimer's peptides A beta 25-35 and A beta 31-35: Reverse-turn conformation and side-chain interactions revealed by X-ray diffraction. J. Struct. Biol. 141 (2003) 156-170
24. Booker G.W., Gout I., Downing A.K., Driscoll P.C., Boyd J., Waterfield M.D., and Campbell I.D. Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell 73 (1993) 813-822
25. Bouchard M., Zurdo J., Nettleton E.J., Dobson C.M., and Robinson C.V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9 (2000) 1960-1967
26. Bousset L., Belrhali H., Janin J., Melki R., and Morera S. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae. Structure (Camb.) 9 (2001) 39-46
27. Bousset L., Briki F., Doucet J., and Melki R. The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. J. Struct. Biol. 141 (2003) 132-142
28. Bousset L., Redeker V., Decottignies P., Dubois S., Le Marechal P., and Melki R. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p. Biochemistry 43 (2004) 5022-5032
29. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267 (1992) 546-554
30. Burke M.J., and Rougvie M.A. Cross-beta protein structures. I. Insulin fibrils. Biochemistry 11 (1972) 2435-2439
31. Burkoth T.S., Benzinger T.L.S., Urban V., Morgan D.M., Gregory D.M., Thiyagarajan P., Botto R.E., Meredith S.C., and Lynn D.G. Structure of the beta-amyloid(10-35) fibril. J. Am. Chem. Soc. 122 (2000) 7883-7889
32. Carter D.B., and Chou K.C. A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils. Neurobiol. Aging 19 (1998) 37-40
33. Castano E.M., Ghiso J., Prelli F., Gorevic P.D., Migheli A., and Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem. Biophys. Res. Commun. 141 (1986) 782-789
34. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., and Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30 (1991) 7672-7680
35. Chan J.C., Oyler N.A., Yau W.M., and Tycko R. Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry 44 (2005) 10669-10680
36. Chapman J.A., Tzaphlidou M., Meek K.M., and Kadler K.E. The collagen fibril-a model system for studying the staining and fixation of a protein. Electron Microsc. Rev. 3 (1990) 143-182
37. Chiu C.Y., Cary R.B., Chen D.J., Peterson S.R., and Stewart P.L. Cryo-EM imaging of the catalytic subunit of the DNA-dependent protein kinase. J. Mol. Biol. 284 (1998) 1075-1081
38. Cohen A.S. General introduction and a brief history of amyloidosis. In: Marrink J., and van Rijswijk M.H. (Eds). "Amyloidosis" (1986), Martinus Nijhoff Publishers, Dordrecht 3-19
39. Cohen A.S., and Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183 (1959) 1202-1203
40. Crestfield A.M., Stein W.H., and Moore S. Properties and conformation of the histidine residues at the active site of ribonuclease. J. Biol. Chem. 238 (1963) 2421-2428
41. DeLano W.L. "The PyMol Molecular Graphics System." (2002), DeLano Scientific, San Carlos, CA
42. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (1993) 1047-1051
43. Dische F.E., Wernstedt C., Westermark G.T., Westermark P., Pepys M.B., Rennie J.A., Gilbey S.G., and Watkins P.J. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 31 (1988) 158-161
44. Divry P., and Florkin M. Sur les propriétés optiques de l'amyloide. C. R. Soc. Biol. (Paris) 97 (1927) 1808-1810
45. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
46. Dos Reis S., Coulary-Salin B., Forge V., Lascu I., Begueret J., and Saupe S.J. The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils. J. Biol. Chem. 277 (2002) 5703-5706
47. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., and Obradovic Z. Intrinsic disorder and protein function. Biochemistry 41 (2002) 6573-6582
48. D'Ursi A.M., Armenante M.R., Guerrini R., Salvadori S., Sorrentino G., and Picone D. Solution structure of amyloid beta-peptide (25-35) in different media. J. Med. Chem. 47 (2004) 4231-4238
49. Eanes E.D., and Glenner G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16 (1968) 673-677
50. Ekiel I., and Abrahamson M. Folding-related dimerization of human cystatin C. J. Biol. Chem. 271 (1996) 1314-1321
51. Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., Hasnain S.S., Hayward L.J., Valentine J.S., Yeates T.O., and Hart P.J. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 10 (2003) 461-467
52. Fändrich M., and Dobson C.M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21 (2002) 5682-5690
53. Fändrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
54. Fändrich M., Forge V., Buder K., Kittler M., Dobson C.M., and Diekmann S. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc. Natl. Acad. Sci. USA 100 (2003) 15463-15468
55. Fay N., Redeker V., Savistchenko J., Dubois S., Bousset L., and Melki R. Structure of the prion Ure2p in protein fibrils assembled in vitro. J. Biol. Chem. 280 (2005) 37149-37158
56. Floege J., and Ehlerding G. Beta-2-microglobulin-associated amyloidosis. Nephron 72 (1996) 9-26
57. Fraser P.E., Duffy L.K., O'Malley M.B., Nguyen J., Inouye H., and Kirschner D.A. Morphology and antibody recognition of synthetic beta-amyloid peptides. J. Neurosci. Res. 28 (1991) 474-485
58. Fraser P.E., McLachlan D.R., Surewicz W.K., Mizzen C.A., Snow A.D., Nguyen J.T., and Kirschner D.A. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. J. Mol. Biol. 244 (1994) 64-73
59. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264 (1989) 7761-7764
60. Gasset M., Baldwin M.A., Fletterick R.J., and Prusiner S.B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA 90 (1993) 1-5
61. Glass N.L., Jacobson D.J., and Shiu P.K. The genetics of hyphal fusion and vegetative incompatibility in filamentous ascomycete fungi. Annu. Rev. Genet. 34 (2000) 165-186
62. Glenner G.G., and Wong C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
63. Gordon D.J., Balbach J.J., Tycko R., and Meredith S.C. Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. Biophys. J. 86 (2004) 428-434
64. Gorevic P.D., Castano E.M., Sarma R., and Frangione B. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem. Biophys. Res. Commun. 147 (1987) 854-862
65. Gosal W.S., Morten I.J., Hewitt E.W., Smith D.A., Thomson N.H., and Radford S.E. Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J. Mol. Biol. 351 (2005) 850-864
66. Gotte G., Bertoldi M., and Libonati M. Structural versatility of bovine ribonuclease A. Distinct conformers of trimeric and tetrameric aggregates of the enzyme. Eur. J. Biochem. 265 (1999) 680-687
67. Govaerts C., Wille H., Prusiner S.B., and Cohen F.E. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc. Natl. Acad. Sci. USA 101 (2004) 8342-8347
68. Gregory D.M., Benzinger T.L., Burkoth T.S., Miller-Auer H., Lynn D.G., Meredith S.C., and Botto R.E. Dipolar recoupling NMR of biomolecular self-assemblies: Determining inter- and intrastrand distances in fibrilized Alzheimer's beta-amyloid peptide. Solid State Nucl. Magn. Reson. 13 (1998) 149-166
69. Gueft B., and Ghidoni J.J. The site of formation and ultrastructure of amyloid. Am. J. Pathol. 43 (1963) 837-854
70. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., and Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 95 (1998) 4224-4228
71. Guo J.-T., Wetzel R., and Xu Y. Molecular modeling of the core of Abeta amyloid fibrils. Proteins 57 (2004) 357-364
72. Halverson K., Fraser P.E., Kirschner D.A., and Lansbury Jr. P.T. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic beta-protein fragments. Biochemistry 29 (1990) 2639-2644
73. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., and Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol. 218 (1991) 149-163
74. Hoshino M., Katou H., Hagihara Y., Hasegawa K., Naiki H., and Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat. Struct. Biol. 9 (2002) 332-336
75. Hurshman A.R., White J.T., Powers E.T., and Kelly J.W. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43 (2004) 7365-7381
76. Inouye H., and Kirschner D.A. Alzheimer's beta-amyloid: Insights into fibril formation and structure from Congo red binding. Subcell. Biochem. 38 (2005) 203-224
77. Inouye H., Fraser P.E., and Kirschner D.A. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: Analysis by x-ray diffraction. Biophys. J. 64 (1993) 502-519
78. Ippel J.H., Olofsson A., Schleucher J., Lundgren E., and Wijmenga S.S. Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc. Natl. Acad. Sci. USA 99 (2002) 8648-8653
79. Ivanova M.I., Gingery M., Whitson L.J., and Eisenberg D. Role of the C-terminal 28 residues of beta2-microglobulin in amyloid fibril formation. Biochemistry 42 (2003) 13536-13540
80. Ivanova M.I., Sawaya M.R., Gingery M., Attinger A., and Eisenberg D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc. Natl. Acad. Sci. USA 101 (2004) 10584-10589
81. Jackson M., and Mantsch H.H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 95-120
82. Janowski R., Kozak M., Jankowska E., Grzonka Z., Grubb A., Abrahamson M., and Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8 (2001) 316-320
83. Jenkins J., and Pickersgill R. The architecture of parallel beta-helices and related folds. Prog. Biophys. Mol. Biol. 77 (2001) 111-175
84. Jerala R., and Zerovnik E. Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. J. Mol. Biol. 291 (1999) 1079-1089
85. Jiménez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C.M., Sunde M., and Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18 (1999) 815-821
86. Jiménez J.L., Nettleton E.J., Bouchard M., Robinson C.V., Dobson C.M., and Saibil H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. USA 99 (2002) 9196-9201
87. Jones S., Manning J., Kad N.M., and Radford S.E. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. J. Mol. Biol. 325 (2003) 249-257
88. Kajava A.V., Baxa U., Wickner R.B., and Steven A.C. A model for Ure2p prion filaments and other amyloids: The parallel superpleated beta-structure. Proc. Natl. Acad. Sci. USA 101 (2004) 7885-7890
89. Kajava A.V., Aebi U., and Steven A.C. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 348 (2005) 247-252
90. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
91. Kartha G., Bello J., and Harker D. Tertiary structure of ribonuclease. Nature 213 (1967) 862-865
92. Kellermayer M.S., Grama L., Karsai A., Nagy A., Kahn A., Datki Z.L., and Penke B. Reversible mechanical unzipping of amyloid beta-fibrils. J. Biol. Chem. 280 (2005) 8464-8470
93. Kendrew J.C., Dickerson R.E., Strandberg B.E., Hart R.G., Davies D.R., Phillips D.C., and Shore V.C. Structure of myoglobin-three-dimensional Fourier synthesis at 2-Å resolution. Nature 185 (1960) 422-427
94. Kirschner D.A., Abraham C., and Selkoe D.J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. USA 83 (1986) 503-507
95. Kirschner D.A., Inouye H., Duffy L.K., Sinclair A., Lind M., and Selkoe D.J. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84 (1987) 6953-6957
96. Kiselev N.A., Sherman M.B., and Tsuprun V.L. Negative staining of proteins. Electron Microsc. Rev. 3 (1990) 43-72
97. Kishimoto A., Hasegawa K., Suzuki H., Taguchi H., Namba K., and Yoshida M. beta-Helix is a likely core structure of yeast prion Sup35 amyloid fibers. Biochem. Biophys. Res. Commun. 315 (2004) 739-745
98. Klafki H.W., Pick A.I., Pardowitz I., Cole T., Awni L.A., Barnikol H.U., Mayer F., Kratzin H.D., and Hilschmann N. Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro. Biol. Chem. Hoppe Seyler 374 (1993) 1117-1122
99. Klunk W.E., Pettegrew J.W., and Abraham D.J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 37 (1989) 1273-1281
100. Knaus K.J., Morillas M., Swietnicki W., Malone M., Surewicz W.K., and Yee V.C. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8 (2001) 770-774
101. Koch K.M. Dialysis-related amyloidosis. Kidney Int. 41 (1992) 1416-1429
102. Komar A.A., Melki R., and Cullin C. The [URE3] yeast prion: From genetics to biochemistry. Biochemistry (Mosc.) 64 (1999) 1401-1407
103. Kozhukh G.V., Hagihara Y., Kawakami T., Hasegawa K., Naiki H., and Goto Y. Investigation of a peptide responsible for amyloid fibril formation of beta 2-microglobulin by achromobacter protease I. J. Biol. Chem. 277 (2002) 1310-1315
104. Krishnan R., and Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435 (2005) 765-772
105. Lai Z., Colon W., and Kelly J.W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35 (1996) 6470-6482
106. Lansbury Jr. P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., Halverson K.J., Kocisko D.A., Hendsch Z.S., Ashburn T.T., Spencer R.G., et al. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2 (1995) 990-998
107. Lashuel H.A., Lai Z., and Kelly J.W. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: Implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry 37 (1998) 17851-17864
108. Liu R., McAllister C., Lyubchenko Y., and Sierks M.R. Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation. J. Neurosci. Res. 75 (2004) 162-171
109. Liu Y., Gotte G., Libonati M., and Eisenberg D. A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 8 (2001) 211-214
110. Liu Y., Gotte G., Libonati M., and Eisenberg D. Structures of the two 3D domain-swapped RNase A trimers. Protein Sci. 11 (2002) 371-380
111. Makin O.S., and Serpell L.C. Structures for amyloid fibrils. FEBS J. 272 (2005) 5950-5961
112. Makin O.S., Atkins E., Sikorski P., Johansson J., and Serpell L.C. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. USA 102 (2005) 315-320
113. Malinchik S.B., Inouye H., Szumowski K.E., and Kirschner D.A. Structural analysis of Alzheimer's beta(1-40) amyloid: Protofilament assembly of tubular fibrils. Biophys. J. 74 (1998) 537-545
114. Masison D.C., and Wickner R.B. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270 (1995) 93-95
115. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82 (1985) 4245-4249
116. McKinley M.P., Meyer R.K., Kenaga L., Rahbar F., Cotter R., Serban A., and Prusiner S.B. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65 (1991) 1340-1351
117. McParland V.J., Kalverda A.P., Homans S.W., and Radford S.E. Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat. Struct. Biol. 9 (2002) 326-331
118. McPhie P. CD studies on films of amyloid proteins and polypeptides: Quantitative g-factor analysis indicates a common folding motif. Biopolymers 75 (2004) 140-147
119. Missmahl H.P., and Hartwig M. Polarisationsoptische untersuchungen an der amyloidsubstanz. Virchows Arch. Pathol. Anat. 324 (1953) 489-508
120. Monti M., Principe S., Giorgetti S., Mangione P., Merlini G., Clark A., Bellotti V., Amoresano A., and Pucci P. Topological investigation of amyloid fibrils obtained from beta2-microglobulin. Protein Sci. 11 (2002) 2362-2369
121. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., and Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435 (2005) 773-778
122. Nguyen J.T., Inouye H., Baldwin M.A., Fletterick R.J., Cohen F.E., Prusiner S.B., and Kirschner D.A. X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 252 (1995) 412-422
123. Nilsson M., Wang X., Rodziewicz-Motowidlo S., Janowski R., Lindstrom V., Onnerfjord P., Westermark G., Grzonka Z., Jaskolski M., and Grubb A. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: Use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J. Biol. Chem. 279 (2004) 24236-24245
124. Olafsson I., and Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid 7 (2000) 70-79
125. Olofsson A., Ippel H.J., Baranov V., Horstedt P., Wijmenga S., and Lundgren E. Capture of a dimeric intermediate during transthyretin amyloid formation. J. Biol. Chem. 276 (2001) 39592-39599
126. Olofsson A., Ippel J.H., Wijmenga S.S., Lundgren E., and Ohman A. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279 (2004) 5699-5707
127. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., and Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90 (1993) 10962-10966
128. Parge H.E., Hallewell R.A., and Tainer J.A. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 89 (1992) 6109-6113
129. Pelton J.T., and McLean L.R. Spectroscopic methods for analysis of protein secondary structure. Anal. Biochem. 277 (2000) 167-176
130. Pepys M.B. Amyloidosis. Annu. Rev. Med. 57 (2006) 8.1-8.19
131. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., Rozenshteyn R., James T.L., Houghten R.A., Cohen F.E., Prusiner S.B., and Burton D.R. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273 (1997) 614-622
132. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91 (1994) 5355-5358
133. Perutz M.F., Finch J.T., Berriman J., and Lesk A. Amyloid fibers are water-filled nanotubes. Proc. Natl. Acad. Sci. USA 99 (2002) 5591-5595
134. Perutz M.F., Pope B.J., Owen D., Wanker E.E., and Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc. Natl. Acad. Sci. USA 99 (2002) 5596-5600
135. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., and Tycko R. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 99 (2002) 16742-16747
136. Petkova A.T., Buntkowsky G., Dyda F., Leapman R.D., Yau W.M., and Tycko R. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J. Mol. Biol. 335 (2004) 247-260
137. Petty S.A., and Decatur S.M. Experimental evidence for the reorganization of beta-strands within aggregates of the Abeta(16-22) peptide. J. Am. Chem. Soc. 127 (2005) 13488-13489
138. Prelli F., Castano E., Glenner G.G., and Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51 (1988) 648-651
139. Prusiner S.B., McKinley M.P., Bowman K.A., Bolton D.C., Bendheim P.E., Groth D.F., and Glenner G.G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35 (1983) 349-358
140. Puchtler H., Sweat F., and Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10 (1962) 355-364
141. Richardson J.S., and Richardson D.C. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA 99 (2002) 2754-2759
142. Ritter C., Maddelein M.L., Siemer A.B., Lührs T., Ernst M., Meier B.H., Saupe S.J., and Riek R. Correlation of structural elements and infectivity of the HET-s prion. Nature 435 (2005) 844-848
143. Rochet J.C., and Lansbury Jr. P.T. Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
144. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
145. Roterman I., KrUl M., Nowak M., Konieczny L., Rybarska J., Stopa B., Piekarska B., and Zemanek G. Why Congo red binding is specific for amyloid proteins-model studies and a computer analysis approach. Med. Sci. Monit. 7 (2001) 771-784
146. Safar J., Roller P.P., Gajdusek D.C., and Gibbs Jr. C.J. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268 (1993) 20276-20284
147. Saibil H.R. Macromolecular structure determination by cryo-electron microscopy. Acta Crystallogr. D Biol. Crystallogr. 56 Pt. 10 (2000) 1215-1222
148. Sambashivan S., Liu Y., Sawaya M.R., Gingery M., and Eisenberg D. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437 (2005) 266-269
149. Sanger F. Chemistry of insulin; determination of the structure of insulin opens the way to greater understanding of life processes. Science 129 (1959) 1340-1344
150. Saper M.A., Bjorkman P.J., and Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219 (1991) 277-319
151. Saraiva M.J. Transthyretin mutations in health and disease. Hum. Mutat. 5 (1995) 191-196
152. Saupe S.J. Molecular genetics of heterokaryon incompatibility in filamentous ascomycetes. Microbiol. Mol. Biol. Rev. 64 (2000) 489-502
153. Schlunegger M.P., Bennett M.J., and Eisenberg D. Oligomer formation by 3D domain swapping: A model for protein assembly and misassembly. Adv. Protein Chem. 50 (1997) 61-122
154. Selkoe D.J. Alzheimer's disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53 (1994) 438-447
155. Selkoe D.J. Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271 (1996) 18295-18298
156. Serag A.A., Altenbach C., Gingery M., Hubbell W.L., and Yeates T.O. Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks. Biochemistry 40 (2001) 9089-9096
157. Serag A.A., Altenbach C., Gingery M., Hubbell W.L., and Yeates T.O. Arrangement of subunits and ordering of beta-strands in an amyloid sheet. Nat. Struct. Biol. 9 (2002) 734-739
158. Serpell L.C., and Smith J.M. Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol. 299 (2000) 225-231
159. Serpell L.C., Sunde M., Fraser P.E., Luther P.K., Morris E.P., Sangren O., Lundgren E., and Blake C.C. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254 (1995) 113-118
160. Serpell L.C., Blake C.C., and Fraser P.E. Molecular structure of a fibrillar Alzheimer's A beta fragment. Biochemistry 39 (2000) 13269-13275
161. Serpell L.C., Sunde M., Benson M.D., Tennent G.A., Pepys M.B., and Fraser P.E. The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300 (2000) 1033-1039
162. Shanmugam G., and Jayakumar R. Structural analysis of amyloid beta peptide fragment (25-35) in different microenvironments. Biopolymers 76 (2004) 421-434
163. Shirahama T., and Cohen A.S. High-resolution electron microscopic analysis of the amyloid fibril. J. Cell Biol. 33 (1967) 679-708
164. Shirahama T., Benson M.D., Cohen A.S., and Tanaka A. Fibrillar assemblage of variable segments of immunoglobulin light chains: An electron microscopic study. J. Immunol. 110 (1973) 21-30
165. Shivaprasad S., and Wetzel R. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking. Biochemistry 43 (2004) 15310-15317
166. Sikorski P., and Atkins E. New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. Biomacromolecules 6 (2005) 425-432
167. Sikorski P., Atkins E.D., and Serpell L.C. Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment. Structure (Camb.) 11 (2003) 915-926
168. Smith D.P., Jones S., Serpell L.C., Sunde M., and Radford S.E. A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. J. Mol. Biol. 330 (2003) 943-954
169. Staniforth R.A., Giannini S., Higgins L.D., Conroy M.J., Hounslow A.M., Jerala R., Craven C.J., and Waltho J.P. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20 (2001) 4774-4781
170. Stork M., Giese A., Kretzschmar H.A., and Tavan P. Molecular dynamics simulations indicate a possible role of parallel beta-helices in seeded aggregation of poly-Gln. Biophys. J. 88 (2005) 2442-2451
171. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., and Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273 (1997) 729-739
172. Taylor K.L., Cheng N., Williams R.W., Steven A.C., and Wickner R.B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283 (1999) 1339-1343
173. Thakur A.K., and Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 99 (2002) 17014-17019
174. Tjernberg L.O., Callaway D.J., Tjernberg A., Hahne S., Lilliehook C., Terenius L., Thyberg J., and Nordstedt C. A molecular model of Alzheimer amyloid beta-peptide fibril formation. J. Biol. Chem. 274 (1999) 12619-12625
175. Török M., Milton S., Kayed R., Wu P., McIntire T., Glabe C.G., and Langen R. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277 (2002) 40810-40815
176. Turk E., Teplow D.B., Hood L.E., and Prusiner S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176 (1988) 21-30
177. Turnell W.G., and Finch J.T. Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J. Mol. Biol. 227 (1992) 1205-1223
178. Umland T.C., Taylor K.L., Rhee S., Wickner R.B., and Davies D.R. The crystal structure of the nitrogen regulation fragment of the yeast prion protein Ure2p. Proc. Natl. Acad. Sci. USA 98 (2001) 1459-1464
179. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999) 735-741
180. Virchow R. Zur Cellulose-Frage. Virchows Arch. Pathol. Anat. 6 (1854) 415-426
181. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 272 (2005) 5942-5949
182. Westermark P., Sletten K., Johansson B., and Cornwell III G.G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA 87 (1990) 2843-2845
183. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., Masters C.L., Merlini G., Saraiva M.J., and Sipe J.D. Amyloid fibril protein nomenclature-2002. Amyloid 9 (2002) 197-200
184. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., Masters C.L., Merlini G., Saraiva M.J., and Sipe J.D. Amyloid: Toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12 (2005) 1-4
185. Wetzel R. Ideas of order for amyloid fibril structure. Structure (Camb.) 10 (2002) 1031-1036
186. Wille H., Zhang G.F., Baldwin M.A., Cohen F.E., and Prusiner S.B. Separation of scrapie prion infectivity from PrP amyloid polymers. J. Mol. Biol. 259 (1996) 608-621
187. Wille H., Michelitsch M.D., Guénebaut V., Supattapone S., Serban A., Cohen F.E., Agard D.A., and Prusiner S.B. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99 (2002) 3563-3568
188. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping Abeta amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
189. Wolman M., and Bubis J.J. The cause of the green polarization color of amyloid stained with Congo red. Histochemie 4 (1965) 351-356
190. Wood S.J., Wetzel R., Martin J.D., and Hurle M.R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry 34 (1995) 724-730
191. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G., and Wuthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97 (2000) 145-150
192. Zerovnik E., Jerala R., Kroon-Zitko L., Turk V., and Lohner K. Characterization of the equilibrium intermediates in acid denaturation of human stefin B. Eur. J. Biochem. 245 (1997) 364-372